ACM
NEO icon

Anfield Capital Management’s NeoGenomics NEO Stock Holding History

Anfield Capital Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-150
Closed -$2.36K – 485
2024
Q1 		$2.36K Buy
+150
New +$2.32K ﹤0.01% 240

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Anfield Capital Management's NEO Position: Q2 2024 in Review

Anfield Capital Management sold out of NeoGenomics (NEO) in Q2 2024, closing a stake of 150 shares — an estimated $2.36K sold.

Anfield Capital Management first reported a position in NEO in Q1 2024 and held it in 1 quarter. The position peaked at $2.36K in Q1 2024. 259 funds tracked by Wall St. Rank hold NEO as of Q2 2024.

  • Anfield Capital Management reported no remaining NeoGenomics position as of Q2 2024 after selling out during the quarter.
  • Anfield Capital Management sold 150 NeoGenomics shares in Q2 2024, an estimated $2.36K.
  • Anfield Capital Management first reported a position in NeoGenomics in Q1 2024 and held it in 1 quarter.
  • Anfield Capital Management's NeoGenomics position peaked at $2.36K in Q1 2024.
  • 259 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2024.

Based on Anfield Capital Management's 13F filing for Q2 2024, filed 31 Jul 2024.